Abstract
Liver transplantation has become the treatment of choice for a wide range of end-stage liver disease. As outcomes have improved, so the demand for this therapy has increasingly exceeded the availability of donor organs. Access to liver transplantation is controlled such that donor organs are generally allocated to the patients who are likely to benefit most, although if all patients who might benefit were placed on the waiting list, the donor shortage would be greatly increased.
Recurrence of the original liver disease is emerging as an important issue. Fewer pa-tients are transplanted for liver tumors, as earlier results showed a very high rate of recur-rence. In recent years there has been a change in the underlying conditions of patients on the waiting list, and a preponderance of patients now present with hepatitis C and alcoholic cirrhosis.
Increasingly, transplant units are looking to sources of donor organs that would pre-viously have been deemed unsuitable-such marginal donors include non-heart-beating donors (NHBDs). Results from controlled NHBDs-those cases in which cardiac arrest is predicted-suggest that this is a good source of viable organs.
Splitting a donor liver to provide two grafts has successful enabled the transplanta-tion of a child and an adult from one organ. The transplantation of two adults from a single organ remains a greater challenge.
Transplantation from living donors has been practiced increasingly over the last decade, although anxieties have been expressed over donor safety. In many countries this now represents a significant contribution to overall liver transplant activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Starzl T. M., Marchioro T. L., and Von Kaulia K. N. (1963) Homotransplanta-tion of the liver in humans. Surg. Gynecol. Obstet. 117, 659–676.
Starzl T. E., Iwatsuki S., Van Thiel D. H., et al. (1982) Evolution of liver trans-plantation. Hepatology 2, 614–636.
(1984). National Institute’s of Health Consensus Development Conference State-ment: Liver Transplantation. Hepatolog; 4, 107S–110S.
Jain A., Reyes J., Kashyap R., et al. (2000) Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann. Surg. 232, 490–500.
Gordon R. D., Fung J., Tzakis A. G., et al. (1991) Liver transplantation at the University of Pittsburgh, 1984 to 1990. Clin. Transplant. 105–117.
Abbasoglu O., Levy M. F., Brkic B. B., et al. (1997) Ten years of liver trans-plantation: an evolving understanding of late graft loss. Transplantation 64, 1801–1807.
Asfar S., Metrakos P., Fryer J., et al. (1996). An analysis of late deaths after liver transplantation. Transplantation 61, 1377–1381.
Neuberger J., Adams D., Macmaster P., Maidment A., and Speed M. (1998) Assessing priorities for allocation of donor liver grafts: survey of public and clini-cians. BMJ 317,172–175.
Kamath P. S., Wiesner R. H., Malinchoc M., et al. (2001) A model to predict survival in patients with end stage liver disease. Hepatology 33, 464–470.
UNOS. Policy 3.6.: Allocation of livers. Available at: http://www.org/organDatasource/OrganSpecificPolicies.asp?display=Liver., Accessed August 13,2003.
Freeman R. B., Rohrer R. J., Katz E., et al. (2001) Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes wait-ing time. Liver Transplant. 7, 173–178.
Select Committee of Experts on the Organisational Aspects of Cooperation in Organ Transplantation. Meeting the organ shortage: current status and strategies for improvement of cadaveric organ donation. Madrid: ONT, 1996.
Kim W. R. (2002) The burden of hepatitis C in the United States. Hepatology 36, S30–S34.
Berenguer M.., Prieto M., Rayon J. M., et al. (2000) Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation. Hepa-tology 32, 852–858.
Han S. H., Martin P., Edelstein M., et al. (2003) Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long term prophylaxis to prevent hepa-titis B recurrence after liver transplantation. Liver Transplant. 9, 182–187.
Clemente G., Duran F., Loinaz C., et al. (1999) Late orthotopic liver retrans-plant indications and survival. Liver Transplant Spanish Group. Transplant Proc. 31, 511–514.
Jain A., Demetris A. J., Kashyap R,. et al. (2001) Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognosic factors in 1048 liver transplants with a mean follow-up of 6 years. Liver Transplant. 7, 623–630.
O’Grady J.G., Burroughs A., Hardy P., Elbourne D., Troesdale A., and the UK and Republic of Ireland Liver Transplant Study Group (2002) Tacrolimus versus microemulsified ciclosporine in liver transplantation: the TMC randomised con-trolled trial. Lancet 360, 1119–1125.
Jain A., Mazariegos G., Polzharna R., et al. (2003) The absence of chronic rejection in paediatric primary liver transplant patients who are maintained on tacrolimus based immunosuppression: a long-term analysis. Transplantation 75, 1020–1025.
Yokosuka O. (2000) Role of steroid priming in the treatment of chronic hepatitis. Br. J. Gastroenterol. Hepatol. (Suppl.), E41–45.
Heffron T.G., Smallwood G.A., Oakley B., et al. (2002) Autoimmune hepatitis following liver transplantation: relationship to recurrent disease and steroid wean-ing. Transplant. Proc. 34, 3311–3312.
Mazariegos G., Reyes J., Marino I.R., et al. (1997) Weaning of immunosup-pression in liver transplant recipients. Transplantation 63, 243–249.
Mazariegos G. V., Reyes J., Webber S. A., et al. (2002) Cytokine gene poly-morphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation 73, 1432–1435.
Buhler L. H., Spitzer T. R., Sykes M., et al. (2002) Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with mul-tiple myeloma and end-stage renal disease. Transplantation 74, 1405–1409.
Busuttil R. W. and Goss J. A. (1999) Split liver transplantation. Ann. Surg. 229, 313–321.
New W., Solomon M., Dingwall R., and McHale J. (1994) A question of give and take: improving the supply of donor organs for transplantation. Research report, Kings Fund Institute, 18.
Briggs J. D., Crombie A., Fabre J., Major E., Thorogood J., and Veitch P. S. (1997) Organ donation in the UK: a survey by a British Transplantation Society working party. Nephrol. Dial. Transplant. 12, 2251–2257.
Ploeg R. J., D’Alessandro A. M., Knechtle S. J., et al. (1993) Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Trans-plantation 55, 807–813.
Makowka L., Gordon R. D., Todo S., et al. (1987) Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant. Proc. 19, 2378–2382.
Rull R., Vidal O., Momblan D., et al. (2003) Evaluation of potential liver donors: Limits imposed by donor variables in liver transplantation. Liver Trans-plant. 9, 389–393.
Salizzoni M., Franchello A., Zamboni F., et al. (2003) Marginal grafts: finding the correct treatment for fatty livers. Transplant. Int. 16, 486–493. Epub 2003 Mar 28.
Tekin K., Imber C. J., Atli M., et al. (2004) A simple scoring system to evalu-ate the effects of cold ischaemia on marginal donors. Transplantation 77, 411–416.
Strasberg M., Howard T. K., Molmenti E. P., and Hertl M. (1994) Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation [see comments]. Hepatology 20, 829–838.
Bismuth H. and Houssin D. (1984) Reduced size orthotopic liver graft in hepatic transplantation in children. Surgery 95, 367–370.
Broelsch C. E., Emond J. C., and Thistlewaite J. R. (1988) Liver transplantation including the concept of reduced size liver transplants in children. Ann. Surg. 208, 410–420.
Ringe B., Pichlmayr R., and Burdelski M. (1988) A new technique of hepatic vein reconstruction in partial liver transplantation. Transplant. Int. 1, 3035.
Strong R., Ong T. H., Pillayb P., Wall D., Balderson G., and Lynch S. (1988) A new method of segmental orthotopic liver transplantation in children. Surgery 104, 104–107.
de Santibanes E., McCormack L., and Mattera J. (2000) Partial left lateral seg-ment transplant from a living donor. Liver Transplant. 6, 108–112.
Badger I. L., Czerniak A., and Beath S. (1992) Hepatic transplantation in chil-dren using reduced size grafts. Br. J. Surg. 79, 47–49.
Houssin D., Soubrane O., Boillot O., et al. (1992) Orthotopic liver transplanta-tion with a reduced-size graft: an ideal compromise in paediatrics? Surgery 111, 532–542.
Malatack J. J., Schaid D. J., Urbach A. H., et al. (1987) Choosing a paediatric recipient for orthotopic liver transplantation. J. Pediatr. Surg. 111, 479–489.
Pichlmayr R., Ringe B., Gubernatis G., and Hauss J. (1988) Transplantation of a donor liver to two recipients (splitting transplantation)-a new method in the further development of segmental liver transplantation. Langenbecks Arch. Chir. 373, 127–130.
Rogiers, X., Malago,M., Gawad,K., et al. (1996) In situ splitting of cadaveric livers. The ultimate expanion of a limited donor pool. Ann.Surg. 224, 331–339.
Bismuth H, Morino M, Castaing D, et al. (1989) Emergency orthotopic liver transplantation in two patients using one donor liver. Br. J. Surg. 76, 722–724.
Strong R. W., Lych S. V., Hin Ong T. H., Matsunami H., and Koido Y. (1990) Successful liver transplantation from a living donor to her son. N. Engl. J. Med.. 322, 1505–1507.
Gomez M., Garcia-Buitron J. M., Fernandez-Garcia A, et al. (1997) Liver trans-plantation with organs from non-heart-beating donors. Transplant. Proc. 29, 3478–3479.
Casavilla A., Ramirez C., Shapiro R., et al (1995) Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 59, 197–203.
D’Alessandro A. M., Hoffmann R. M., Knechtle S. J., et al. (1995) Successful extrarenal transplantation from non-heart-beating donors. Transplantation 59, 977–982.
Reich D. J., Munoz S. J., Rothstein K. D., et al. (2000) Controlled non-heart-beating donor liver transplantation: a successful single centre experience, with topic update. Transplantation 70, 1159–1166.
Otero A., Gomez-Gutierrez M., Suarez F., et al. (2003) Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation 76, 1068–1073.
Rela M., Muiesan P., Vilca-Melendez H., et al. (1999) Auxiliary partial orthoto-pic liver transplantation for Crigler-Najjar syndrome type I. Ann. Surg. 229, 565–569.
Uemoto S., Yabe S., Inomata Y., et al. (1997) Coexistenct of a graft with the preserved native liver in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency. Transplantation 63, 1026–1028.
Saudubray J. M., Touati G., Delonlay P., et al. (1999) Liver transplantation in propionic acidaemia. Eur J Pediatr. 158, S65–S69.
van Hoek B., de Boer J., Boudjema K., Williams R., Corsmit O., et al (1999) Auxiliary versus orthotopic liver transplantation for acute liver failure. J. Hepa-tol. 30, 699–705.
Langnas A. N., Fox I. J., Heffron T. G., et al. (1995) University of Nabraska Medical Centre Liver Transplant Program. Clin. Transplant. 177–185.
Starzl T. E., Fung J. J., Tzakis A. G., et al. (1993) Baboon-to-human liver trans-plantation. Lancet 341, 65–71.
Makowka L., Cramer D. V., Hoffman A., et al. (1995) The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Trans-plantation 59, 1654–1659.
Waterworth P. D., Cozzi E., and Tolan M. J. (1997) Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy. Transplant. Proc. 29, 899–900.
McGregor C. G., Teotia S. S., and Schirmer J. M. (2003) Advances in preclinical cardiac xenotransplantation [abstr 47]. J. Heart Lung Transplant. 22, S89–S89.
Phelps C. J., Koike C., Vaught T. D., et al. (2003) Production of alpha-1,3 galactosyltransferase-deficient pigs. Science. 299, 411–414.
Oldmixon B., Wood J. C., Ericsson T. A., et al. (2002) Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J. Virol. 76, 3045–3048.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Friend, P.J., Imber, C.J. (2006). Current Status of Liver Transplantation. In: Hornick, P., Rose, M. (eds) Transplantation Immunology. Methods In Molecular Biology™, vol 333. Humana Press. https://doi.org/10.1385/1-59745-049-9:29
Download citation
DOI: https://doi.org/10.1385/1-59745-049-9:29
Publisher Name: Humana Press
Print ISBN: 978-1-58829-544-6
Online ISBN: 978-1-59745-049-2
eBook Packages: Springer Protocols